Literature DB >> 34344058

Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle-aged and older Chinese population: A cross-sectional analysis.

Yixin Niu1, Weiwei Zhang1, Hongmei Zhang1, Xiaoyong Li1, Ning Lin1, Weikang Su2, Hongxia Gu3, Lingfei Zhu1, Jiangao Fan4, Li Qin1,3, Zhen Yang1, Qing Su1.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is now regarded as the hepatic manifestation of metabolic syndrome (MetS). Recent research has suggested that serum creatinine (SCr) may be an indicator of MetS and its related diseases. We aimed to investigate the association between SCr and NAFLD in Chinese adults.
METHODS: A cross-sectional sample of 8862 subjects aged 40 years or older (40-73 years) from China were analysed in this study. The anthropometric measurements, laboratory tests, and hepatic ultrasonography were conducted. NAFLD presence was defined by hepatic ultrasound in the absence of other liver diseases.
RESULTS: NAFLD subjects had higher SCr than those without NAFLD (66.8 μmol/L vs. 65.6 μmol/L, p < 0.001). Moreover, SCr levels were correlated with alanine aminotransferase (β = 0.099, p < 0.001), aspartate aminotransferase (β = 0.135, p < 0.001), γ-glutamyltransferase (β = 0.039, p < 0.001), and insulin resistance (β = 0.027, p = 0.014) after adjusted for potential covariates. In the multivariable-adjusted logistic regression analyses, compared to the first SCr quintile, the odds ratio for NAFLD was 1.35 (95% confidence interval 1.14-1.60, p < 0.001) for the fifth quintile after adjusting multiple measured confounders.
CONCLUSION: SCr concentration is independently associated with NAFLD in a middle aged and older Chinese population. Elevated SCr levels, even within normal ranges, were associated with higher risk of NAFLD.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  insulin resistance; metabolic syndrome; non-alcoholic fatty liver disease; serum creatinine

Mesh:

Substances:

Year:  2021        PMID: 34344058     DOI: 10.1002/dmrr.3489

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  3 in total

1.  Association of serum creatinine with hepatic steatosis and fibrosis: a cross-sectional study.

Authors:  Juan Ma; Zhongcao Wei; Qian Wang; Xiaolan Lu; Zhihua Zhou; Ruohan Li; Qiuai Shu; Yixin Liu; Jinhai Wang; Na Liu; Haitao Shi
Journal:  BMC Gastroenterol       Date:  2022-07-27       Impact factor: 2.847

2.  Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients.

Authors:  Ka Shing Cheung; Lok Ka Lam; Rex Wan Hin Hui; Xianhua Mao; Ruiqi R Zhang; Kwok Hung Chan; Ivan Fn Hung; Wai Kay Seto; Man-Fung Yuen
Journal:  Clin Mol Hepatol       Date:  2022-05-11

3.  Creatinine accelerates APAP-induced liver damage by increasing oxidative stress through ROS/JNK signaling pathway.

Authors:  Fang Liu; Yan Liu; Qifeng Peng; Guodong Wang; Qing Tan; Zhongyue Ou; Qishan Xu; Chixiang Liu; Daming Zuo; Jianbo Zhao
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.